Yakult Honsha Co.,Ltd Announces Consolidated and Non-Consolidated Earnings Results for the Second Quarter Ended September 30, 2018; Provides Consolidated and Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2019
November 08, 2018
Share
Yakult Honsha Co.,Ltd announced consolidated and non-consolidated earnings results for the second quarter ended September 30, 2018. For the quarter on consolidated basis, net sales were JPY 203,507 million against JPY 197,728 million for the same period a year ago. Operating profit was JPY 23,795 million against JPY 22,806 million for the same period a year ago. Profit was JPY 23,875 million against JPY 19,977 million for the same period a year ago.
For the quarter on non-consolidated basis, net sales were JPY 93,547 million against JPY 90,132 million for the same period a year ago. Operating profit was JPY 924 million against JPY 2,666 million for the same period a year ago. Profit was JPY 5,477 million against JPY 5,721 million for the same period a year ago.
The company provided consolidated and non-consolidated earnings guidance for the fiscal year ending March 31, 2019. On consolidated basis, the company expects net sales of JPY 418,000 million, operating profit of JPY 48,000 million, profit attributable to owners of parent is expected to be JPY 39,000 million.
On non-consolidated basis, the company expects net sales of JPY 182,000 million, operating profit of JPY 1,500 million and profit attributable to owners of parent of JPY 15,500 million.
YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.
Yakult Honsha Co.,Ltd Announces Consolidated and Non-Consolidated Earnings Results for the Second Quarter Ended September 30, 2018; Provides Consolidated and Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2019